Q1FY25 EARNING CALENDAR at a glance: BRITANNIA, CAMS, DALMIASUG
AHMEDABAD, 2 AUGUST
IMPORTANT EX-DIVIDEND TODAY
AJMERA REALTY | Rs 4 |
ALBERT DAVID | Rs 11.5 |
CELLO WORLD | Rs 1.5 |
CIPLA | Rs 13 |
COFORGE | Rs 19 |
DIVIS LAB | Rs 30 |
GLOSTER | Rs 20 |
INDIGO PAINTS | Rs 3.5 |
JUBILANT INGREVIA | Rs 2.5 |
JUBILANT PHARMOVA | Rs 5 |
MARUTI SUZUKI | Rs 125 |
MATRIMONY | Rs 5 |
MUNJAL SHOWA | Rs 4.5 |
NARAYANA HRUDAYALAYA | Rs 4 |
VEDANTA | Rs 4 |
WPIL | Rs 20 |
BRITANNIA: Revenue expected at Rs 4191 crore versus Rs 4010 crore, EBITDA expected to be seen at Rs 777 crore versus Rs 688 crore, EBITDA margin expected to be seen at 18.53 % versus 17.15 %
Net profit expected to be seen at Rs 530 crore versus Rs 457 crore
HINDZINC
Revenue expected at Rs 7915 crore versus Rs 7282 crore
EBITDA expected to be seen at Rs 3982 crore versus Rs 3347 crore
EBITDA margin expected to be seen at 50.30 % versus 45.96 %
Net profit expected to be seen at Rs 2273 crore versus Rs 1964 crore
LICHSGFIN
NII expected at Rs 2187 crore versus Rs 2209 crore
EBIT expected to be seen at Rs 1915 crore versus Rs 2009 crore
EBIT margin expected to be seen at 86.37 % versus 89.20 %
Net profit expected to be seen at Rs 1230 crore versus Rs 1323 crore
TITAN
2.8.2024
Revenue expected at Rs 11,993 crore versus Rs 11,897 crore
EBITDA expected to be seen at Rs 1162 crore versus Rs 1125 crore
EBITDA margin expected to be seen at 9.69 % versus 9.45 %
Net profit expected to be seen at Rs 764 crore versus Rs 753 crore
02.08.2024: | AEROFLEX, BRITANNIA, CAMS, DALMIASUG, DELHIVERY, DHAMPURSUG, DHANUKA, HINDZINC, IDFC, INFIBEAM, IONEXCHANG, KIRLOSBROS, LICHSGFIN, MEDPLUS, PAUSHAKLTD, PSPPROJECT, RANEHOLDIN, RENUKA, SAMHI, SFL, SHARDAMOTR, SMLISUZU, SUDARSCHEM, TAJGVK, TEXINFRA, TITAN, TMB, UPL, ZYDUSWELL |
UPL
Revenue expected at Rs 8833 crore versus Rs 8963 crore
EBITDA expected to be seen at Rs 1153 crore versus Rs 1592 crore
EBITDA margin expected to be seen at 13.05 % versus 17.76 %
Net profit expected to be seen at Rs (313) crore versus Rs 209 crore
03.08.2024 | AFFLE,ARE&M, BANKINDIA, CGCL, DIVISLAB, EVEREADY, GAEL, GOKULAGRO, HIMATSEIDE, JKTYRE, KUANTUM, NUCLEUS, SARDAEN, SBIN, UTKARSHBNK, ZUARI |
ARE&M
Revenue expected at Rs 3083 crore versus Rs 2769 crore
EBITDA expected to be seen at Rs 454 crore versus Rs 353 crore
EBITDA margin expected to be seen at 14.72% versus 12.74%
Net profit expected to be seen at Rs 264 crore versus Rs 192 crore
DIVISLAB
Revenue expected at Rs 2060 crore versus Rs 1778 crore
EBITDA expected to be seen at Rs 615 crore versus Rs 504 crore
EBITDA margin expected to be seen at 29.85% versus 28.34%
Net profit expected to be seen at Rs 445 crore versus Rs 356 crore
JKTYRE
Revenue expected at Rs 3874 crore versus Rs 3718 crore
EBITDA expected to be seen at Rs 505 crore versus Rs 685 crore
EBITDA margin expected to be seen at 13.03% versus 18.42%
Net profit expected to be seen at Rs 207 crore versus Rs 149 crore
SBIN
NII expected at Rs 41, 990 crore versus Rs 38,905 crore
EBIT expected to be seen at Rs 25,431 crore versus Rs 22,795 crore
EBIT margin expected to be seen at 47.27% versus 44.72%
Net profit expected to be seen at Rs 16,867 crore versus Rs 16,884 crore
05.08.2024: | ARTIPHARM, ANDHRAPAP, AVANTIFEED, BEML, BHARTIARTL, BHARTIHEXA, BLS, BLSE, BRIGADE, CENTURYPLY, CUPID, DEEPAKNTR, DEEPINDS, DEVYANI, EIHAHOTELS, EXICOM, GSFC, HAWKINCOOK, HCC, HGINFRA, HONAUT, INDRAMEDCO, MANGLMCEM, MARICO, MSUMI, MUKANDLTD, ONGC, ORIENTCEM, PARAS, REFEX, RUSTOMJEE, SANDUMA, SCHNEIDER, SDBL, SMSPHARMA, SPARC, SUVEN, SYRMA, TAJGVK, TATACHEM, TRITURBINE, VIJAYA, VMART, VRLLOG |
BHARTIARTL
Revenue expected at Rs 38,530 crore versus Rs 37,440 crore
EBITDA expected to be seen at Rs 19,970 crore versus Rs 19,598 crore
EBITDA margin expected to be seen at 51.82% versus 52.34%
Net profit expected to be seen at Rs 3785 crore versus Rs 5028 crore
DEEPAKNTR
Revenue expected at Rs 2070 crore versus Rs 1768 crore
EBITDA expected to be seen at Rs 316 crore versus Rs 209 crore
EBITDA margin expected to be seen at 15.26% versus 11.82%
Net profit expected to be seen at Rs 207 crore versus Rs 149 crore
MARICO
Revenue expected at Rs 2660 crore versus Rs 2477 crore
EBITDA expected to be seen at Rs 627 crore versus Rs 574 crore
EBITDA margin expected to be seen at 23.57% versus 23.17%
Net profit expected to be seen at Rs 462 crore versus Rs 427 crore
MSUMI
Revenue expected at Rs 2219 crore versus Rs 1858 crore
EBITDA expected to be seen at Rs 271 crore versus Rs 194 crore
EBITDA margin expected to be seen at 12.21% versus 10.44%
Net profit expected to be seen at Rs 174 crore versus Rs 123 crore
TATACHEM
Revenue expected at Rs 3686 crore versus Rs 4218 crore
EBITDA expected to be seen at Rs 511 crore versus Rs 1043 crore
EBITDA margin expected to be seen at 13.86% versus 24.72%
Net profit expected to be seen at Rs 114 crore versus Rs 523 crore
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ, ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)